₹ 0.0 Cr
Volume Transacted
(Dec 5, 2024)
0.0 K
Stocks Traded
(Dec 5, 2024)
Last Updated on: Dec 05, 2024
Divis Laboratories Ltd
NSE: DIVISLAB
ISIN
INE361B01024
Last updated on: Dec 05, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Divis Laboratories Ltd
NSE: DIVISLAB
Share Price
₹ 6232
-25.95 (-0.41%)
Last updated on: Dec 05, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
04 Dec 2024 | 6257.95 | 6220.8 | 6265.15 | 6184.9 |
03 Dec 2024 | 6210.35 | 6280 | 6289.5 | 6200 |
02 Dec 2024 | 6250.2 | 6448.75 | 6448.75 | 6172 |
29 Nov 2024 | 6171.05 | 6034.95 | 6205.8 | 6002.45 |
28 Nov 2024 | 5953.6 | 6003 | 6019 | 5901 |
27 Nov 2024 | 6000.95 | 6123.3 | 6123.3 | 5986.65 |
26 Nov 2024 | 6071.65 | 6142.25 | 6148.85 | 6009.3 |
25 Nov 2024 | 6140.7 | 5999.75 | 6185 | 5999.75 |
22 Nov 2024 | 5999.4 | 5998.65 | 6056.1 | 5982.8 |
21 Nov 2024 | 5975.7 | 5944.95 | 6002.6 | 5884.55 |
Date | Price (₹) |
---|---|
04 Dec 2024 | 6257.95 |
03 Dec 2024 | 6210.35 |
02 Dec 2024 | 6250.2 |
29 Nov 2024 | 6171.05 |
28 Nov 2024 | 5953.6 |
27 Nov 2024 | 6000.95 |
26 Nov 2024 | 6071.65 |
25 Nov 2024 | 6140.7 |
22 Nov 2024 | 5999.4 |
21 Nov 2024 | 5975.7 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 05 Dec 09:08 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Divis Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Divis Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Divis Laboratories Ltd spurts 1.29%, gains for five straight sessions
Divis Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs...
25 Nov 2024 13:00
Divi's Labs PAT soars 47% YoY to Rs 510 crore in Q2
Total income grew by 22.51% year on year (YoY) to Rs 2,444 crore in the quarter ended 30 S...
09 Nov 2024 16:09
Divis Laboratories declare Quarterly Result
Divis Laboratories will hold a meeting of the Board of Directors of the Company on 9 Novem...
30 Oct 2024 14:53
Divis Laboratories Ltd slips for fifth straight session
Divis Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at...
23 Oct 2024 13:35
CARE Ratings reaffirms ratings of Divi's Labs with 'stable' outlook
The agency has also affirmed the company's short term rating at 'CARE A1+'. CARE Ratings s...
16 Sep 2024 12:01
Divis Laboratories receives affirmation in credit ratings for bank facilities
Divis Laboratories has received reaffirmation in credit ratings for bank facilities aggreg...
14 Sep 2024 15:10
Unlimited trading starting at just Rs. 249*